LAQ824

CAS No. 404951-53-7

LAQ824 ( Dacinostat )

Catalog No. M14389 CAS No. 404951-53-7

LAQ824 (Dacinostat) is a novel HDAC inhibitor with IC50 of 32 nM and is known to activate the p21 promoter.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 56 In Stock
5MG 101 In Stock
10MG 170 In Stock
25MG 305 In Stock
50MG 462 In Stock
100MG 669 In Stock
500MG 1368 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LAQ824
  • Note
    Research use only, not for human use.
  • Brief Description
    LAQ824 (Dacinostat) is a novel HDAC inhibitor with IC50 of 32 nM and is known to activate the p21 promoter.
  • Description
    LAQ824 (Dacinostat) is a novel HDAC inhibitor with IC50 of 32 nM and is known to activate the p21 promoter.
  • Synonyms
    Dacinostat
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    404951-53-7
  • Formula Weight
    379.46
  • Molecular Formula
    C22H25N3O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 76 mg/mL (200.28 mM)
  • SMILES
    O=C(NO)/C=C/C1=CC=C(CN(CCO)CCC2=CNC3=C2C=CC=C3)C=C1
  • Chemical Name
    (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Atadja P, et al. Y Res, 2004, 64(2), 689-695.
molnova catalog
related products
  • GSK-3117391

    GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.

  • BRD 8184

    BRD 8184 is a potent, selective HDAC6 inhibitor with IC50 of 8 nM.

  • ACY-738

    ACY-738 (ACY738) is a potent and specific HDAC6 inhibitor (IC50=1.7 nM) with improved brain bioavailability; displays 60-1500 fold selectivity over class I HDACs.